Yuzhuo Z Wang

59PUBLICATIONS
278CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (59)

|Apr 13, 2026
PARP Inhibition in Prostate Cancer: Current Status, Resistance Mechanisms, and Clinical Challenges.

Takashi Matsuoka, Shusuke Akamatsu, Christopher J Ong

|Oct 27, 2025
Transcription Factor Dynamics in Neuroendocrine Prostate Cancer Development.

Yu Wang, Yuzhuo Wang

|Jun 04, 2025
Longitudinal single-cell analysis reveals RUNX1T1 as an early driver in treatment-induced neuroendocrine transdifferentiation.

Yuchao Ni, Dong Lin, Mingchen Shi

|May 29, 2025
Author Correction: Class I HDAC inhibitors enhance YB-1 acetylation and oxidative stress to block sarcoma metastasis.

Amal M El-Naggar, Syam Prakash Somasekharan, Yemin Wang

|May 19, 2025
Exploiting pre-dormancy tumor immune microenvironment induced by androgen deprivation in prostate cancer.

Nelson K Y Wong, Ning Kang, Claire Dourieu

Pageof 10